title: Perinatal parvovirus B19 infections: what are the clinical consequences?
authors.forename: S K
authors.initials: SK
authors.lastname: Wiersbitzky
authors.forename: E
authors.initials: E
authors.lastname: Beyersdorff
authors.forename: C
authors.initials: C
authors.lastname: Mueller
authors.forename: R
authors.initials: R
authors.lastname: Bruns
authors.forename: B
authors.initials: B
authors.lastname: Eberhard
authors.forename: C
authors.initials: C
authors.lastname: Burtzlaff
authors.forename: H
authors.initials: H
authors.lastname: Wiersbitzky
mesh_terms: D000914:Antibodies, Viral / Q000097:blood; D004279:DNA, Viral / Q000097:blood; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007231:Infant, Newborn; D010322:Parvoviridae Infections / Q000150:complications*; D016732:Parvovirus B19, Human / Q000276:immunology
chemical_list: D000914:Antibodies, Viral; D004279:DNA, Viral; D007074:Immunoglobulin G